Small Molecule Active Pharmaceutical Ingredient Market Report

Global and Region Small Molecule Active Pharmaceutical Ingredient Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：168
  • REPORT CODE：GMM909618
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Small Molecule Active Pharmaceutical Ingredient market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Small Molecule Active Pharmaceutical Ingredientmarket, defines the market attractiveness level of Small Molecule Active Pharmaceutical Ingredient market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Small Molecule Active Pharmaceutical Ingredient industry, describes the types of Small Molecule Active Pharmaceutical Ingredient market, the applications of major players and the market size, and deeply analyzes the current situation of the global Small Molecule Active Pharmaceutical Ingredient market and the development prospects and opportunities of Small Molecule Active Pharmaceutical Ingredient industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Small Molecule Active Pharmaceutical Ingredient market in Chapter 13.

    By Player:

    • Siegfried Holding AG

    • PCAS

    • Cambrex Corporation

    • Novartis AG,

    • Bristol-Myers Squibb

    • Bachem Holding AG

    • Teva Pharmaceuticals

    • Boehringer Ingelheim GmbH

    • GlaxoSmithKline

    • Pfizer

    • AstraZeneca

    • Johnson & Johnson

    • Johnson Matthey

    • BASF SE

    • Roche

    By Type:

    • Standard API

    • High Potency API

    By End-User:

    • Cardiovascular Diseases

    • Respiratory Disorders

    • Infectious Diseases

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Small Molecule Active Pharmaceutical Ingredient Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Small Molecule Active Pharmaceutical Ingredient Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Small Molecule Active Pharmaceutical Ingredient Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Small Molecule Active Pharmaceutical Ingredient Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Small Molecule Active Pharmaceutical Ingredient Market Analysis and Outlook to 2022

    • 7.1 Global Small Molecule Active Pharmaceutical Ingredient Consumption (2017-2022)

    • 7.2 United States Small Molecule Active Pharmaceutical Ingredient Consumption (2017-2022)

    • 7.3 Europe Small Molecule Active Pharmaceutical Ingredient Consumption (2017-2022)

    • 7.4 China Small Molecule Active Pharmaceutical Ingredient Consumption (2017-2022)

    • 7.5 Japan Small Molecule Active Pharmaceutical Ingredient Consumption (2017-2022)

    • 7.6 India Small Molecule Active Pharmaceutical Ingredient Consumption (2017-2022)

    • 7.7 South Korea Small Molecule Active Pharmaceutical Ingredient Consumption (2017-2022)

    8 Region and Country-wise Small Molecule Active Pharmaceutical Ingredient Market Analysis and Outlook to 2028

    • 8.1 Global Small Molecule Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)

    • 8.2 United States Small Molecule Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)

    • 8.3 Europe Small Molecule Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)

    • 8.4 China Small Molecule Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)

    • 8.5 Japan Small Molecule Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)

    • 8.6 India Small Molecule Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)

    • 8.7 South Korea Small Molecule Active Pharmaceutical Ingredient Consumption Forecast (2022-2028)

    9 Global Small Molecule Active Pharmaceutical Ingredient Market Outlook by Types and Applications to 2022

    • 9.1 Global Small Molecule Active Pharmaceutical Ingredient Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Standard API Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global High Potency API Consumption and Growth Rate (2017-2022)

    • 9.2 Global Small Molecule Active Pharmaceutical Ingredient Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Respiratory Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Infectious Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Small Molecule Active Pharmaceutical Ingredient Market Outlook by Types and Applications to 2028

    • 10.1 Global Small Molecule Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Standard API Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global High Potency API Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Small Molecule Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Respiratory Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Small Molecule Active Pharmaceutical Ingredient Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Small Molecule Active Pharmaceutical Ingredient Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Small Molecule Active Pharmaceutical Ingredient Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Small Molecule Active Pharmaceutical Ingredient Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Small Molecule Active Pharmaceutical Ingredient Market Competitive Analysis

    • 14.1 Siegfried Holding AG

      • 14.1.1 Siegfried Holding AG Company Details

      • 14.1.2 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.2 PCAS

      • 14.2.1 PCAS Company Details

      • 14.2.2 PCAS Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 PCAS Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.3 Cambrex Corporation

      • 14.3.1 Cambrex Corporation Company Details

      • 14.3.2 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.4 Novartis AG,

      • 14.4.1 Novartis AG, Company Details

      • 14.4.2 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.5 Bristol-Myers Squibb

      • 14.5.1 Bristol-Myers Squibb Company Details

      • 14.5.2 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.6 Bachem Holding AG

      • 14.6.1 Bachem Holding AG Company Details

      • 14.6.2 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.7 Teva Pharmaceuticals

      • 14.7.1 Teva Pharmaceuticals Company Details

      • 14.7.2 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.8 Boehringer Ingelheim GmbH

      • 14.8.1 Boehringer Ingelheim GmbH Company Details

      • 14.8.2 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.9 GlaxoSmithKline

      • 14.9.1 GlaxoSmithKline Company Details

      • 14.9.2 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.10 Pfizer

      • 14.10.1 Pfizer Company Details

      • 14.10.2 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.11 AstraZeneca

      • 14.11.1 AstraZeneca Company Details

      • 14.11.2 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.12 Johnson & Johnson

      • 14.12.1 Johnson & Johnson Company Details

      • 14.12.2 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.13 Johnson Matthey

      • 14.13.1 Johnson Matthey Company Details

      • 14.13.2 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.14 BASF SE

      • 14.14.1 BASF SE Company Details

      • 14.14.2 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Product and Service

    • 14.15 Roche

      • 14.15.1 Roche Company Details

      • 14.15.2 Roche Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Roche Small Molecule Active Pharmaceutical Ingredient Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Small Molecule Active Pharmaceutical Ingredient

    • Figure Small Molecule Active Pharmaceutical Ingredient Picture

    • Table Global Small Molecule Active Pharmaceutical Ingredient Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Consumption by Country (2017-2022)

    • Figure United States Small Molecule Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)

    • Table Europe Small Molecule Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)

    • Figure Japan Small Molecule Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)

    • Figure India Small Molecule Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)

    • Figure South Korea Small Molecule Active Pharmaceutical Ingredient Consumption and Growth Rate (2017-2022)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028)

    • Figure United States Small Molecule Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Small Molecule Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Small Molecule Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Small Molecule Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Small Molecule Active Pharmaceutical Ingredient Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Standard API Consumption and Growth Rate (2017-2022)

    • Figure Global High Potency API Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Standard API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global High Potency API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Export by Region (Top 5 Countries) (2017-2028)

    • Table Siegfried Holding AG (Foundation Year, Company Profile and etc.)

    • Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table PCAS (Foundation Year, Company Profile and etc.)

    • Table PCAS Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table PCAS Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Cambrex Corporation (Foundation Year, Company Profile and etc.)

    • Table Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Novartis AG, (Foundation Year, Company Profile and etc.)

    • Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Bachem Holding AG (Foundation Year, Company Profile and etc.)

    • Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Johnson Matthey (Foundation Year, Company Profile and etc.)

    • Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table BASF SE (Foundation Year, Company Profile and etc.)

    • Table BASF SE Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table BASF SE Small Molecule Active Pharmaceutical Ingredient Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Small Molecule Active Pharmaceutical Ingredient Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Small Molecule Active Pharmaceutical Ingredient Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US